The Patent Finder

Amcure GmbH

Also on record
Records under this name other than patents Amcure GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Amcure GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,703,796CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,593,146CD44v6-derived peptides for treating metastasizing cancer
Lapsed on the fee record
Ended Mar 14, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 14, 2025USPTO record
US 9,586,993CD44v6-derived peptides for treating pancreatic cancer
Lapsed on the fee record
Ended Mar 7, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 7, 2025USPTO record
US 9,586,994CD44V6-derived peptides for treating breast cancer
Lapsed on the fee record
Ended Mar 7, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 7, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited